Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Ahmet Cingöz et al.|Cell Communication and Signaling|2023Cited by 12
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Ezgi Yağmur Kala et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0